[Esketamine (treatment-resistant major depressive disorder) – Addendum to Commission A23-18]

Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen
Record ID 32018005254
Original Title: Esketamin (therapieresistente Major Depression) - Addendum zum Projekt A23-18
Project Status: Completed
Year Published: 2023
English language abstract: There is no English language summary available
Publication Type: Full HTA
Country: Germany
MeSH Terms
  • Depressive Disorder, Major
  • Depressive Disorder, Treatment-Resistant
  • Depression
  • Antidepressive Agents
  • Ketamine
  • Esketamine
  • Depressive Disorder – Treatment-Resistant
  • Benefit Assessment
  • NCT04338321
Organisation Name: Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address: IQWiG, Im Mediapark, 8, DE-50670 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email: berichte@iqwig.de
Copyright: Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.